Review Article
An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules
Table 7
The overview of the effectiveness of CHM formula granules based on conventional therapy.
| Diseases | No. of studies | Cure rate | Effectiveness rate | CHM granules | Placebo | CHM granules | Placebo |
| Chronic Hepatitis B HBV DNA (HBeAg) | 3 | 47.0% (30.6%) | 28.0% (16.2%) | - | - | Myasthenia gravis | 1 | 0.0% | 0.0% | 90.0% | 88.9% | Herpes simplex keratitis | 1 | 70.1% | 42.9% | 100.0% | 96.8% | Depression | 1 | 37.5% | 24.2% | 87.5% | 75.8% | COPD | 3 | - | - | 93.2% | 82.3% | Diabetic peripheral neuropathy | 1 | - | - | 87.5% | 70.2% | Angina pectoris | 1 | - | - | 75.9% | 66.7% |
|
|
P<0.05 (result of individual study or meta-analysis). |